Applied Therapeutics Inc (APLT)
4.185
-0.06
(-1.53%)
USD |
NASDAQ |
May 17, 16:00
4.185
0.00 (0.00%)
After-Hours: 20:00
Applied Therapeutics Enterprise Value: 332.30M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 332.30M |
| May 16, 2024 | 339.15M |
| May 15, 2024 | 356.29M |
| May 14, 2024 | 383.72M |
| May 13, 2024 | 359.72M |
| May 10, 2024 | 355.15M |
| May 09, 2024 | 381.43M |
| May 08, 2024 | 391.72M |
| May 07, 2024 | 404.16M |
| May 06, 2024 | 401.88M |
| May 03, 2024 | 397.31M |
| May 02, 2024 | 371.03M |
| May 01, 2024 | 360.75M |
| April 30, 2024 | 358.46M |
| April 29, 2024 | 345.90M |
| April 26, 2024 | 342.47M |
| April 25, 2024 | 336.76M |
| April 24, 2024 | 345.90M |
| April 23, 2024 | 363.03M |
| April 22, 2024 | 357.32M |
| April 19, 2024 | 353.90M |
| April 18, 2024 | 395.02M |
| April 17, 2024 | 405.30M |
| April 16, 2024 | 441.86M |
| April 15, 2024 | 431.58M |
| Date | Value |
|---|---|
| April 12, 2024 | 443.00M |
| April 11, 2024 | 463.57M |
| April 10, 2024 | 481.85M |
| April 09, 2024 | 489.84M |
| April 08, 2024 | 500.12M |
| April 05, 2024 | 513.83M |
| April 04, 2024 | 529.83M |
| April 03, 2024 | 562.96M |
| April 02, 2024 | 581.24M |
| April 01, 2024 | 576.67M |
| March 31, 2024 | 630.36M |
| March 28, 2024 | 670.44M |
| March 27, 2024 | 675.74M |
| March 26, 2024 | 656.68M |
| March 25, 2024 | 665.15M |
| March 22, 2024 | 665.15M |
| March 21, 2024 | 673.09M |
| March 20, 2024 | 681.03M |
| March 19, 2024 | 613.26M |
| March 18, 2024 | 581.50M |
| March 15, 2024 | 587.85M |
| March 14, 2024 | 566.67M |
| March 13, 2024 | 597.38M |
| March 12, 2024 | 586.79M |
| March 11, 2024 | 621.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-41.24M
Minimum
Mar 14 2022
1.164B
Maximum
Feb 05 2020
251.55M
Average
181.05M
Median
Enterprise Value Benchmarks
| Fate Therapeutics Inc | 60.40M |
| Viking Therapeutics Inc | 6.425B |
| Outset Medical Inc | 156.61M |
| Terns Pharmaceuticals Inc | 140.94M |
| Edgewise Therapeutics Inc | 1.159B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -83.94M |
| Revenue (Quarterly) | 0.19M |
| Total Expenses (Quarterly) | 21.28M |
| EPS Diluted (Quarterly) | -0.67 |
| Profit Margin (Quarterly) | -44.18K% |
| Earnings Yield | -43.91% |
| Normalized Earnings Yield | -17.13 |